Page last updated: 2024-08-24

1,2,4-triazine and Diabetes Mellitus, Type 2

1,2,4-triazine has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, L; Guo, S; Shen, J; Wang, K; Wang, X; Xie, X; Xiong, M; Xu, T; Yun, Y; Zhao, T1
Alhowail, A; Ali, M; Chigurupati, S; Khan, KM; Perveen, S; Salar, U; Shamim, S; Taha, M; Ullah, N; Ur Rehman, A; Wadood, A1

Other Studies

2 other study(ies) available for 1,2,4-triazine and Diabetes Mellitus, Type 2

ArticleYear
Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists.
    Journal of medicinal chemistry, 2023, 06-22, Volume: 66, Issue:12

    Topics: Animals; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Mice; Obesity

2023
Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase.
    Bioorganic chemistry, 2020, Volume: 101

    Topics: Acarbose; alpha-Amylases; alpha-Glucosidases; Diabetes Mellitus, Type 2; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Triazines

2020